Pfizer Inc (MIL:1PFE)
€ 24.625 -0.215 (-0.87%) Market Cap: 139.23 Bil Enterprise Value: 192.39 Bil PE Ratio: 35.39 PB Ratio: 1.61 GF Score: 64/100

Pfizer Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 08:00PM GMT
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Albert Bourla, Chairman and CEO of Pfizer. Albert, first of all, Happy New Year. Great speaking with you today. I thought you'd have a tough act to follow this year after your 2021 presentation with -- at that point, all the progress you've made on the vaccine. But you managed to top it this year, both with the vaccine front and now with the antiviral. So obviously, congrats on the tremendous success you've had here.

Before we kick it off with the conversation, I know, Chris, I think you're going to run through a quick disclosure, and then we'll jump right into it from there. So over to you, Chris.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Great. Thank you, Chris. So Albert's going to be making forward-looking statements in the course of this presentation. These statements are current only as of today, and we undertake no

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot